These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1484348)

  • 21. Intracellular accumulation of cytosine arabinoside in murine normal and neoplastic lymphocytes following their exposure to sodium 2-mercaptoethanesulphonate.
    Jastrzebski Z; Czyzewska-Szafran H; Remiszewska M; Côte-Rozanes C
    Leuk Res; 1993 Sep; 17(9):815-20. PubMed ID: 8371580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the relationship between therapeutic schedule and antitumor effect of etoposide and cytosine arabinoside in murine L1210 leukemia].
    Ooi K; Ohkubo T; Kawasaki H; Sakurai M
    Yakugaku Zasshi; 1989 Nov; 109(11):865-8. PubMed ID: 2614669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ
    Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric analysis of the cell cycle of the leukemic cell lines treated with etoposide and cytosine arabinoside.
    Ishiyama K; Satoh S; Igarashi Y; Kumagai H; Yahagi A; Sasaki H
    Tohoku J Exp Med; 1994 Oct; 174(2):95-107. PubMed ID: 7900157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity.
    Tanaka M; Yoshida S
    Jpn J Cancer Res; 1987 Aug; 78(8):851-7. PubMed ID: 3115933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
    Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA
    Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells.
    Bhalla K; Birkhofer M; Arlin Z; Grant S; Lutzky J; Graham G
    Leukemia; 1988 Dec; 2(12):810-3. PubMed ID: 3264363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kinetics of etoposide cytotoxicity against mouse P388 leukemia].
    Takahashi K; Iwabuchi M
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2190-5. PubMed ID: 2415068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A synergistic increase of apoptosis utilizing Fas antigen expression induced by low doses of anticancer drug.
    Akiyama H; Ino T; Tokunaga E; Katsuda I; Ezaki K
    Rinsho Byori; 2003 Aug; 51(8):733-9. PubMed ID: 13677932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism and therapeutic efficacy of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P388.
    Avramis VI; Plunkett W
    Cancer Res; 1982 Jul; 42(7):2587-91. PubMed ID: 7083151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effect of interleukin 3 on the metabolism of high-dose cytosine arabinoside in normal versus leukemic human bone marrow cells.
    Bhalla K; Birkhofer M; Arlin Z; Grant S; Lutzky J; Safah H; Graham G
    Exp Hematol; 1991 Aug; 19(7):669-73. PubMed ID: 1893953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic interaction between etoposide and 1-beta-D-arabinofuranosylcytosine.
    Ohkubo T; Hori H; Higashigawa M; Kawasaki H; Kamiya H; Sakurai M; Kagawa Y; Kakito E; Sumida K; Ooi K
    Adv Exp Med Biol; 1989; 253B():355-62. PubMed ID: 2610123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of anti-neoplastic activity of cytosine arabinoside against human HL-60 myeloid leukemic cells by 3-deazauridine.
    Momparler RL; Bouffard DY; Momparler LF; Marquet J; Zittoun J; Marie JP; Zittoun R
    Int J Cancer; 1991 Oct; 49(4):573-6. PubMed ID: 1917159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of in vitro assays for detecting subpopulations of P388 leukemic cells resistant to AraC.
    Raza A; Kuliczkowski K; Weidong G; Preisler HD
    Med Oncol Tumor Pharmacother; 1984; 1(3):163-8. PubMed ID: 6544897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of synergistic cell killing by hydroxyurea and cytosine arabinoside.
    Tanaka M; Kimura K; Yoshida S
    Jpn J Cancer Res; 1985 Aug; 76(8):729-35. PubMed ID: 3930450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antitumor effects of Behenoyl-ara-C (BH-AC) in combination with Idarubicin (IDA) in P 388 leukemic cell bearing mice].
    Watanabe A; Kuriyama H; Kiyota T
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):291-6. PubMed ID: 8712821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro.
    Katagiri T; Miyazawa K; Nishimaki J; Yaguchi M; Kawanishi Y; Ohyashiki K
    Leuk Lymphoma; 2000 Sep; 39(1-2):173-84. PubMed ID: 10975397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
    Ramilo-Torno LV; Avramis VI
    Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
    Cadman E; Eiferman F
    J Clin Invest; 1979 Sep; 64(3):788-97. PubMed ID: 288743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
    Chandrasekaran B; Capizzi RL; Kute TE; Morgan T; Dimling J
    Cancer Res; 1989 Jun; 49(12):3259-66. PubMed ID: 2720678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.